Transcript of Atea Pharmaceuticals, Inc. (AVIR) Earnings Call for Q2 2024
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) had a successful Q2 2024 with strong operational execution and significant clinical progress. The company completed ...
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) had a successful Q2 2024 with strong operational execution and significant clinical progress. The company completed ...
Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.
Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.